Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H23F3O5S.C6H14N2O2.2H2O |
Molecular Weight | 626.683 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.NCCCC[C@H](N)C(O)=O.CCO[C@H](COC1=CC=C(C=C1)C(F)(F)F)CSC2=CC=C(OCC(O)=O)C(C)=C2
InChI
InChIKey=WTKSWPYGZDCUNQ-JZXFCXSPSA-N
InChI=1S/C21H23F3O5S.C6H14N2O2.2H2O/c1-3-27-17(11-28-16-6-4-15(5-7-16)21(22,23)24)13-30-18-8-9-19(14(2)10-18)29-12-20(25)26;7-4-2-1-3-5(8)6(9)10;;/h4-10,17H,3,11-13H2,1-2H3,(H,25,26);5H,1-4,7-8H2,(H,9,10);2*1H2/t17-;5-;;/m10../s1
Molecular Formula | C21H23F3O5S |
Molecular Weight | 444.465 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C6H14N2O2 |
Molecular Weight | 146.1876 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:16:14 UTC 2023
by
admin
on
Sat Dec 16 10:16:14 UTC 2023
|
Record UNII |
N1429130KR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
470715
Created by
admin on Sat Dec 16 10:16:14 UTC 2023 , Edited by admin on Sat Dec 16 10:16:14 UTC 2023
|
||
|
FDA ORPHAN DRUG |
429214
Created by
admin on Sat Dec 16 10:16:14 UTC 2023 , Edited by admin on Sat Dec 16 10:16:14 UTC 2023
|
||
|
FDA ORPHAN DRUG |
543416
Created by
admin on Sat Dec 16 10:16:14 UTC 2023 , Edited by admin on Sat Dec 16 10:16:14 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
N1429130KR
Created by
admin on Sat Dec 16 10:16:14 UTC 2023 , Edited by admin on Sat Dec 16 10:16:14 UTC 2023
|
PRIMARY | |||
|
C174732
Created by
admin on Sat Dec 16 10:16:14 UTC 2023 , Edited by admin on Sat Dec 16 10:16:14 UTC 2023
|
PRIMARY | |||
|
91758782
Created by
admin on Sat Dec 16 10:16:14 UTC 2023 , Edited by admin on Sat Dec 16 10:16:14 UTC 2023
|
PRIMARY | |||
|
928821-40-3
Created by
admin on Sat Dec 16 10:16:14 UTC 2023 , Edited by admin on Sat Dec 16 10:16:14 UTC 2023
|
PRIMARY | |||
|
300000025612
Created by
admin on Sat Dec 16 10:16:14 UTC 2023 , Edited by admin on Sat Dec 16 10:16:14 UTC 2023
|
PRIMARY | |||
|
EF-46
Created by
admin on Sat Dec 16 10:16:14 UTC 2023 , Edited by admin on Sat Dec 16 10:16:14 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
ANHYDROUS->SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |